MolNFT v1 · #173778 · protein
Human TENEURIN4 mut C1
7BAO · Teneurin-4: “Human TENEURIN4 mut C1”. Electron microscopy, 2 ligands (NAG, CA), 20 pockets (best druggability 0.86). MolNFT v1 #173778 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7BAO
- Type
- protein
- Length
- 1,904 residues
- Chains
- 1
- Method
- electron microscopy
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Teneurin-4
- UniProt
- Q6N022
- Ligands
- NAG, CA
- Pockets
- 20 · best druggability 0.86
Structure
electron microscopy · 1 distinct chain · 7% helix, 42% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Teneurin-4 | protein | 1904 | 7% helix, 42% strand | Q6N022 |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 15 copies · chains A
- CA · Calcium ion · metal · 3 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
20 pockets found on a 1 Å grid, 19 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 639 | 0.86 | 0.90 | 79 | empty |
| 2 | 866 | 0.83 | 0.85 | 91 | empty |
| 3 | 297 | 0.83 | 0.94 | 40 | empty |
| 4 | 694 | 0.81 | 0.85 | 67 | empty |
| 5 | 1173 | 0.81 | 0.83 | 106 | empty |
Modifications
Observed in the structure: 11 disulfide, 11 glycan (disulfide, N-glycosylation).
Compared structures
- 7BAO · human Teneurin4 Mut C1 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q6N022
- Elsewhere: RCSB PDB 7BAO · PDBe 7BAO · UniProt Q6N022
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.